Answers are grounded in this paper and cite their sources.
This study describes a simple, rapid method for sensing Cr(vi) using 5-thio-(2-nitrobenzoic acid) modified gold nanoparticles (TNBA-AuNPs) as a remover for Cr(iii) and as a sensor for Cr(vi). We discovered that TNBA-AuNPs were dispersed in the presence of Cr(vi), whereas Cr(iii) induced the aggregation of TNBA-AuNPs. Due to this phenomenon, TNBA-AuNPs can be used as a sorbent material for the removal of >90% Cr(iii), without removing Cr(vi). After centrifuging a solution containing Cr(iii), Cr(vi), and TNBA-AuNPs, Cr(iii) and Cr(vi) were separately present in the precipitate and supernatant. In other words, TNBA-AuNPs are capable of separating a mixture of Cr(iii) and Cr(vi). The addition of ascorbic acid to the supernatant resulted in a reduction of Cr(vi) to Cr(iii), driving the aggregation of TNBA-AuNPs. The selectivity of this approach is more than 1000-fold for Cr(vi) over other metal ions. The minimum detectable concentration of Cr(vi) was 1 μM using this approach. Inductively coupled plasma mass spectrometry provided an alternative for the quantification of Cr(iii) and Cr(vi) after a mixture of Cr(iii) and Cr(vi) had been separated by TNBA-AuNPs. The applicability of this approach was validated through the analysis of Cr(vi) in environmental water samples.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: